Evolent Health, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Evolent Health, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q2 2024.
  • Evolent Health, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $1.6M.
  • Evolent Health, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$74.4M, a 17.1% decline year-over-year.
  • Evolent Health, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$113M, a 490% decline from 2022.
  • Evolent Health, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$19.2M, a 49% increase from 2021.
  • Evolent Health, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$37.6M, a 88.8% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$74.4M $1.6M +$35.9M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$110M -$17.3M +$2.7M +13.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$113M -$33.4M -$22.1M -194% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 -$91M -$25.3M -$27.4M -1293% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-23
Q2 2023 -$63.5M -$34.3M -$29.7M -648% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$33.8M -$20M -$14.6M -273% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$19.2M -$11.3M -$5.7M -101% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 -$13.5M $2.12M +$15.2M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$28.6M -$4.59M +$4.52M +49.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$33.1M -$5.35M +$4.46M +45.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$37.6M -$5.65M +$8.98M +61.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 -$46.6M -$13M +$24.3M +65.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$70.9M -$9.11M +$194M +95.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$265M -$9.81M +$68.9M +87.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$334M -$14.6M +$183M +92.6% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-26
Q3 2020 -$518M -$37.3M -$11.8M -46.3% Jul 1, 2020 Sep 30, 2020 10-K 2021-02-26
Q2 2020 -$506M -$204M -$172M -544% Apr 1, 2020 Jun 30, 2020 10-K 2021-02-26
Q1 2020 -$334M -$78.8M -$32M -68.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$302M -$198M -$181M -1087% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 -$121M -$25.5M -$13.1M -105% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-26
Q2 2019 -$107M -$31.6M -$21.7M -219% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-26
Q1 2019 -$85.8M -$46.7M -$33.1M -243% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-26
Q4 2018 -$52.7M -$16.7M -$3.53M -26.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$49.1M -$12.4M +$159K +1.26% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$49.3M -$9.92M +$6.99M +41.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$56.3M -$13.6M +$4.39M +24.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$60.7M -$13.2M +$4.25M +24.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$64.9M -$12.6M -$1.38M -12.3% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$63.5M -$16.9M -$8.52M -102% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$55M -$18M +$105M +85.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$160M -$17.4M -$13.3M -323% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$146M -$11.2M +$772K +6.44% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$147M -$8.39M -$368M -102% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 $221M -$123M -$111M -984% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 $332M -$4.12M +$6.58M +61.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-03
Q3 2015 $326M -$12M -$8.81M -278% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-03
Q2 2015 $335M $360M +$366M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-03
Q1 2015 -$31.1M -$11.3M -$5.88M -108% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-03
Q4 2014 -$25.2M -$10.7M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$3.17M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$5.94M Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$5.44M Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.